Summit Therapeutics
SMMT
SMMT
93 hedge funds and large institutions have $60.4M invested in Summit Therapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 15 closing their positions.
Holders
93
Holders Change
-7
Holders Change %
-7%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
34
Reduced
22
Closed
15
Calls
$2.1M
Puts
$165K
Net Calls
+$1.93M
Net Calls Change
+$1.99M
Top Buyers
| 1 |
1
Charles Schwab
San Francisco,
California
|
$1.76M |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$5.53M |
| 3 |
3
BlackRock
New York
|
$16.8M |
| 4 |
4
Barclays
London,
United Kingdom
|
$277K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$400K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Creative Planning
Overland Park,
Kansas
| – | -$41.2K | -16,430 | Closed |
|
|
SCA
102
Snowden Capital Advisors
New York
| – | -$31.4K | -12,500 | Closed |
|
103
Balyasny Asset Management
Chicago,
Illinois
| – | -$25.5K | -10,157 | Closed |
|
|
HI
104
Harbour Investments
Madison,
Wisconsin
| – | -$753 | -300 | Closed |
|
|
NC
105
NewSquare Capital
Newtown Square,
Pennsylvania
| – | -$577 | -230 | Closed |
|
|
2L
106
25 LLC
St. Louis,
Missouri
| – | -$440 | -200 | Closed |
|
|
QCG
107
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$445 | -177 | Closed |
|